AKT1 and cancer: With regard to GINS2, it was reported that GINS2 could promote cancer cell proliferation, migration and invasion of non-small-cell lung cancer (NSCLC) via facilitating epithelial-to-mesenchymal transition and modulating PI3K/Akt and MEK/ERK signal pathway [27].